Teladoc Health, Inc. (TDOC)
USD 9.46
(-6.06%)
USD 9.46
(-6.06%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 1.2% |
| 2022 | 1.57 Billion USD | 24.13% |
| 2021 | 1.26 Billion USD | -13.5% |
| 2020 | 1.46 Billion USD | 214.84% |
| 2019 | 465.4 Million USD | 12.23% |
| 2018 | 414.68 Million USD | 99.97% |
| 2017 | 207.37 Million USD | 366.8% |
| 2016 | 44.42 Million USD | 67.78% |
| 2015 | 26.47 Million USD | 1.72% |
| 2014 | 26.02 Million USD | 767.63% |
| 2013 | 3 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.59 Billion USD | -0.13% |
| 2024 Q2 | 1.58 Billion USD | -0.09% |
| 2024 Q3 | 1.57 Billion USD | 0.0% |
| 2023 Q3 | 1.57 Billion USD | -0.1% |
| 2023 FY | 1.59 Billion USD | 1.2% |
| 2023 Q2 | 1.57 Billion USD | 0.11% |
| 2023 Q1 | 1.57 Billion USD | -0.08% |
| 2023 Q4 | 1.59 Billion USD | 1.28% |
| 2022 Q4 | 1.57 Billion USD | -0.14% |
| 2022 Q2 | 1.57 Billion USD | 0.31% |
| 2022 Q1 | 1.57 Billion USD | 24.1% |
| 2022 Q3 | 1.57 Billion USD | -0.15% |
| 2022 FY | 1.57 Billion USD | 24.13% |
| 2021 Q4 | 1.26 Billion USD | 1.06% |
| 2021 Q2 | 1.23 Billion USD | -11.17% |
| 2021 Q1 | 1.39 Billion USD | -4.93% |
| 2021 Q3 | 1.25 Billion USD | 1.34% |
| 2021 FY | 1.26 Billion USD | -13.5% |
| 2020 FY | 1.46 Billion USD | 214.84% |
| 2020 Q3 | 983.81 Million USD | 0.2% |
| 2020 Q4 | 1.46 Billion USD | 48.94% |
| 2020 Q2 | 981.88 Million USD | 103.5% |
| 2020 Q1 | 482.48 Million USD | 3.67% |
| 2019 Q3 | 464.78 Million USD | 1.27% |
| 2019 FY | 465.4 Million USD | 12.23% |
| 2019 Q4 | 465.4 Million USD | 0.13% |
| 2019 Q2 | 458.94 Million USD | 2.16% |
| 2019 Q1 | 449.22 Million USD | 8.33% |
| 2018 Q1 | 210.43 Million USD | 1.48% |
| 2018 FY | 414.68 Million USD | 99.97% |
| 2018 Q2 | 402.75 Million USD | 91.39% |
| 2018 Q3 | 408.65 Million USD | 1.46% |
| 2018 Q4 | 414.68 Million USD | 1.48% |
| 2017 Q4 | 207.37 Million USD | -44.15% |
| 2017 Q3 | 371.33 Million USD | 52.29% |
| 2017 FY | 207.37 Million USD | 366.8% |
| 2017 Q1 | 42.43 Million USD | -4.48% |
| 2017 Q2 | 243.83 Million USD | 474.62% |
| 2016 Q3 | 44.46 Million USD | 41.68% |
| 2016 Q4 | 44.42 Million USD | -0.1% |
| 2016 Q2 | 31.38 Million USD | 19.77% |
| 2016 Q1 | 26.2 Million USD | -1.02% |
| 2016 FY | 44.42 Million USD | 67.78% |
| 2015 Q2 | 32.65 Million USD | 25.38% |
| 2015 FY | 26.47 Million USD | 1.72% |
| 2015 Q4 | 26.47 Million USD | -2.35% |
| 2015 Q3 | 27.11 Million USD | -16.98% |
| 2015 Q1 | 26.04 Million USD | 0.07% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 26.02 Million USD | 0.0% |
| 2014 FY | 26.02 Million USD | 767.63% |
| 2013 FY | 3 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Well Corporation | 11.78 Million USD | -13409.902% |
| Doximity, Inc. | 14.54 Million USD | -10846.494% |
| Evolent Health, Inc. | 644.79 Million USD | -146.943% |
| MultiPlan Corporation | 4.56 Billion USD | 65.142% |
| Phreesia, Inc. | 11.98 Million USD | -13187.799% |
| Veeva Systems Inc. | 55.77 Million USD | -2754.822% |